JP2020506192A - インフルエンザウイルスを阻害するためのピペラジン誘導体 - Google Patents

インフルエンザウイルスを阻害するためのピペラジン誘導体 Download PDF

Info

Publication number
JP2020506192A
JP2020506192A JP2019541718A JP2019541718A JP2020506192A JP 2020506192 A JP2020506192 A JP 2020506192A JP 2019541718 A JP2019541718 A JP 2019541718A JP 2019541718 A JP2019541718 A JP 2019541718A JP 2020506192 A JP2020506192 A JP 2020506192A
Authority
JP
Japan
Prior art keywords
compound according
mmol
compound
influenza
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019541718A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020506192A5 (OSRAM
Inventor
ドンゲン，マリア ヴァン
ドンゲン，マリア ヴァン
ジュラゼク，ヤロスワフ
バート グリエット シェペンス，ウィム
バート グリエット シェペンス，ウィム
ローソン，エドワード，チャールズ
シュック，ブライアン，シー
ヨンカーズ，ティム，ヒューゴ，マリア
ターリ，アブデラ
ラボワッソン，ピエール，ジャン−マリー，ベルナール
バイク，クリストフ，フランシス，ロバート，ネスター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Vaccines and Prevention BV
Original Assignee
Janssen Vaccines and Prevention BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Vaccines and Prevention BV filed Critical Janssen Vaccines and Prevention BV
Priority claimed from PCT/EP2018/052537 external-priority patent/WO2018141854A1/en
Publication of JP2020506192A publication Critical patent/JP2020506192A/ja
Publication of JP2020506192A5 publication Critical patent/JP2020506192A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
JP2019541718A 2017-02-02 2018-02-01 インフルエンザウイルスを阻害するためのピペラジン誘導体 Pending JP2020506192A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762453673P 2017-02-02 2017-02-02
US62/453,673 2017-02-02
EP17156448 2017-02-16
EP17156448.7 2017-02-16
PCT/EP2018/052537 WO2018141854A1 (en) 2017-02-02 2018-02-01 Piperazine derivatives for influenza virus inhibition

Publications (2)

Publication Number Publication Date
JP2020506192A true JP2020506192A (ja) 2020-02-27
JP2020506192A5 JP2020506192A5 (OSRAM) 2021-03-11

Family

ID=61192896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019541718A Pending JP2020506192A (ja) 2017-02-02 2018-02-01 インフルエンザウイルスを阻害するためのピペラジン誘導体

Country Status (5)

Country Link
US (1) US11040963B2 (OSRAM)
EP (1) EP3577107A1 (OSRAM)
JP (1) JP2020506192A (OSRAM)
AU (1) AU2018216954B2 (OSRAM)
CA (1) CA3052353A1 (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10140040B1 (en) 2017-05-25 2018-11-27 Micron Technology, Inc. Memory device with dynamic program-verify voltage calibration
US10452480B2 (en) 2017-05-25 2019-10-22 Micron Technology, Inc. Memory device with dynamic processing level calibration
US10664194B2 (en) 2018-05-16 2020-05-26 Micron Technology, Inc. Memory system with dynamic calibration using a variable adjustment mechanism
US10990466B2 (en) 2018-06-20 2021-04-27 Micron Technology, Inc. Memory sub-system with dynamic calibration using component-based function(s)
US11188416B2 (en) 2018-07-12 2021-11-30 Micron Technology, Inc. Enhanced block management for a memory sub-system
US11113129B2 (en) 2018-07-13 2021-09-07 Micron Technology, Inc. Real time block failure analysis for a memory sub-system
US10936246B2 (en) 2018-10-10 2021-03-02 Micron Technology, Inc. Dynamic background scan optimization in a memory sub-system
BR112022002387A2 (pt) * 2019-12-20 2022-09-06 Landos Biopharma Inc Composto da fórmula z-y-q-y' ou um sal ou éster farmaceuticamente aceitável do mesmo

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009117444A1 (en) * 2008-03-17 2009-09-24 Northeastern University Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors
WO2011015037A1 (en) * 2009-08-05 2011-02-10 The University Of Hongkong Antiviral compounds and methods of making and using there of cross reference to related applications
WO2012033736A1 (en) * 2010-09-08 2012-03-15 Bristol-Myers Squibb Company Novel piperazine analogs as broad-spectrum influenza antivirals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE219766T1 (de) 1993-04-07 2002-07-15 Otsuka Pharma Co Ltd N-acylierte 4-aminopiperidin derivate als aktive bestandteile von peripher gefässerweiternden wikstoffen
US6984652B2 (en) * 2003-09-05 2006-01-10 Warner-Lambert Company Llc Gyrase inhibitors
MY170607A (en) 2006-09-07 2019-08-20 Crucell Holland Bv Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
US8961978B2 (en) 2011-07-14 2015-02-24 Crucell Holland B.V. Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009117444A1 (en) * 2008-03-17 2009-09-24 Northeastern University Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors
WO2011015037A1 (en) * 2009-08-05 2011-02-10 The University Of Hongkong Antiviral compounds and methods of making and using there of cross reference to related applications
WO2012033736A1 (en) * 2010-09-08 2012-03-15 Bristol-Myers Squibb Company Novel piperazine analogs as broad-spectrum influenza antivirals

Non-Patent Citations (23)

* Cited by examiner, † Cited by third party
Title
"CAS REGISTRY NO. 1010208-19-1", DATABASE REGISTRY, [ONLINE], JPN7022000123, 26 March 2008 (2008-03-26), ISSN: 0004812191 *
"CAS REGISTRY NO. 1043164-43-7", DATABASE REGISTRY, [ONLINE], JPN7022000122, 24 August 2008 (2008-08-24), ISSN: 0004812190 *
"CAS REGISTRY NO. 1060384-23-7", DATABASE REGISTRY, [ONLINE], JPN7022000121, 13 October 2008 (2008-10-13), ISSN: 0004812189 *
"CAS REGISTRY NO. 1061519-85-4", DATABASE REGISTRY, [ONLINE], JPN7022000120, 15 October 2008 (2008-10-15), ISSN: 0004812188 *
"CAS REGISTRY NO. 1070317-90-6", DATABASE REGISTRY, [ONLINE], JPN7022000119, 3 November 2008 (2008-11-03), ISSN: 0004812187 *
"CAS REGISTRY NO. 1182613-70-2", DATABASE REGISTRY, [ONLINE], JPN7022000118, 11 September 2009 (2009-09-11), ISSN: 0004812186 *
"CAS REGISTRY NO. 1276639-80-5", DATABASE REGISTRY, [ONLINE], JPN7022000117, 7 April 2011 (2011-04-07), ISSN: 0004812185 *
"CAS REGISTRY NO. 1279504-83-4", DATABASE REGISTRY, [ONLINE], JPN7022000116, 13 April 2011 (2011-04-13), ISSN: 0004812184 *
"CAS REGISTRY NO. 1279856-65-3", DATABASE REGISTRY, [ONLINE], JPN7022000115, 14 April 2011 (2011-04-14), ISSN: 0004812183 *
"CAS REGISTRY NO. 1295931-04-2", DATABASE REGISTRY, [ONLINE], JPN7022000114, 17 May 2011 (2011-05-17), ISSN: 0004812182 *
"CAS REGISTRY NO. 1302739-81-6", DATABASE REGISTRY, [ONLINE], JPN7022000113, 30 May 2011 (2011-05-30), ISSN: 0004812181 *
"CAS REGISTRY NO. 1318561-62-4", DATABASE REGISTRY, [ONLINE], JPN7022000112, 16 August 2011 (2011-08-16), ISSN: 0004812180 *
"CAS REGISTRY NO. 1326151-42-1", DATABASE REGISTRY, [ONLINE], JPN7022000111, 31 August 2011 (2011-08-31), ISSN: 0004812179 *
"CAS REGISTRY NO. 1359374-26-7", DATABASE REGISTRY, [ONLINE], JPN7022000110, 2 March 2012 (2012-03-02), ISSN: 0004812178 *
"CAS REGISTRY NO. 1359477-24-9", DATABASE REGISTRY, [ONLINE], JPN7022000109, 2 March 2012 (2012-03-02), ISSN: 0004812177 *
"CAS REGISTRY NO. 1359626-90-6", DATABASE REGISTRY, [ONLINE], JPN7022000108, 2 March 2012 (2012-03-02), ISSN: 0004812176 *
"CAS REGISTRY NO. 1389625-33-5", DATABASE REGISTRY, [ONLINE], JPN7022000107, 12 August 2012 (2012-08-12), ISSN: 0004812175 *
"CAS REGISTRY NO. 1626913-03-8", DATABASE REGISTRY, [ONLINE], JPN7022000106, 26 September 2014 (2014-09-26), ISSN: 0004812174 *
"CAS REGISTRY NO. 1808856-80-5", DATABASE REGISTRY, [ONLINE], JPN7022000105, 29 September 2015 (2015-09-29), ISSN: 0004812173 *
"CAS REGISTRY NO. 1907589-84-7", DATABASE REGISTRY, [ONLINE], JPN7022000104, 10 May 2016 (2016-05-10), ISSN: 0004812172 *
"CAS REGISTRY NO. 1909199-06-9", DATABASE REGISTRY, [ONLINE], JPN7022000103, 12 May 2016 (2016-05-12), ISSN: 0004812171 *
"CAS REGISTRY NO. 920836-08-4", DATABASE REGISTRY, [ONLINE], JPN7022000124, 14 February 2007 (2007-02-14), ISSN: 0004812192 *
DOU, D ET AL.: "Inhibition of noroviruses by piperazine derivatives", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 22, JPN6022000770, 2012, pages 377 - 379, ISSN: 0004812170 *

Also Published As

Publication number Publication date
US20200010459A1 (en) 2020-01-09
AU2018216954A1 (en) 2019-07-18
AU2018216954B2 (en) 2022-04-14
EP3577107A1 (en) 2019-12-11
CA3052353A1 (en) 2018-08-09
US11040963B2 (en) 2021-06-22

Similar Documents

Publication Publication Date Title
AU2018216954B2 (en) Piperazine derivatives for influenza virus inhibition
AU2013226013B2 (en) Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation and Their Method of Use
TWI639596B (zh) 流感病毒複製之抑制劑
AU2014318832B2 (en) Aza-pyridone compounds and uses thereof
JP6470310B2 (ja) シクロプロパンアミン化合物およびその用途
WO2018141854A1 (en) Piperazine derivatives for influenza virus inhibition
CN109721615A (zh) 流感病毒复制抑制剂及其用途
JP6903658B2 (ja) インフルエンザウィルス感染に使用するための複素環インドール
WO2014058071A1 (ja) シクロプロパンアミン化合物およびその用途
JPWO2003082808A1 (ja) ベンズアミド誘導体
US7626056B2 (en) Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat schizophrenia
EP2858984A1 (en) Inhibitors of influenza viruses replication
WO2020015669A1 (zh) 抗流感病毒三并环衍生物
TW200930703A (en) Quinolone derivative
KR20160052683A (ko) 피리다지논 화합물 및 이의 용도
TWI861165B (zh) 新穎嗒
TWI609015B (zh) 5-Hydroxyindan derivatives containing heterocyclic rings and uses thereof
CN104540810B (zh) 具有抗病毒活性的甲硫酮化合物
JP2021514984A (ja) インフルエンザを処置するためのオルソミクソウイルス複製の阻害剤としての１０−（ジ（フェニル）メチル）−４−ヒドロキシ−８，９，９ａ，１０−テトラヒドロ−７Ｈ−ピロロ［１’，２’：４，５］ピラジノ［１，２−ｂ］ピリダジン−３，５−ジオン誘導体および関連化合物
WO2014092514A1 (ko) 신규한 화합물, 이의 약학적으로 허용가능한 염 또는 이의 광학 이성질체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물
CN114105947B (zh) 一类喹啉衍生物
US20220306646A1 (en) Deuterated Angiotensin-Converting Enzyme-2 (ACE-2) Inhibitors
CN114057731A (zh) 一种哒嗪酮衍生物及其用途
CN113880832A (zh) 一种哒嗪酮衍生物及其用途
WO2013093458A2 (en) Antiviral drug derivatives

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210127

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210127

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20211223

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220325

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220628